相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
Gunn Huh et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis
Heejung Chae et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure
Naoki Mita et al.
JOURNAL OF CLINICAL MEDICINE (2019)
A phase II study of modified FOLFIRINOX for chemotherapy-na < ve patients with metastatic pancreatic cancer
Masato Ozaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer
Kyoko Yamaguchi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer
Kensaku Yoshida et al.
ONCOTARGET (2017)
Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
Alix Portal et al.
BRITISH JOURNAL OF CANCER (2015)
Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity
Yue Zhang et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2015)
Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
Takuji Okusaka et al.
CANCER SCIENCE (2014)
Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis
Susanna B. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy A Randomized Clinical Trial
Ellen M. Lavoie Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
Kojiro Shimozuma et al.
SUPPORTIVE CARE IN CANCER (2009)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)